FLUTEX EFFERVESCENT (tablets)

Land: Sør-Afrika

Språk: engelsk

Kilde: South African Health Products Regulatory Authority (SAHPRA)

Tilgjengelig fra:

Aspen-p

Informasjon til brukeren

INDICATIONS [/za_1102.html#1]
  [/za_1102.html#1]     [/za_1102.html#1]
CONTRA-INDICATIONS [/za_1102.html#1]
      [/za_1102.html#1]
DOSAGE [/za_1102.html#1]
      [/za_1102.html#1]
SIDE-EFFECTS [/za_1102.html#1]
  [/za_1102.html#1]     [/za_1102.html#1]
PREGNANCY [/za_1102.html#1]
      [/za_1102.html#1]
OVERDOSE [/za_1102.html#1]

IDENTIFICATION [/za_1102.html#1]
  [/za_1102.html#1]    PATIENT INFORMATION
FLUTEX EFFERVESCENT (TABLETS)
SCHEDULING STATUS:
S2
PROPRIETARY NAME
(and dosage form):
FLUTEX EFFERVESCENT (TABLETS)
COMPOSITION:
EACH TABLET CONTAINS: 
CHLORPHENIRAMINE
 maleate
        4,0 mg
PARACETAMOL
        500,0 mg
PSEUDOEPHEDRINE
 hydrochloride         50,0 mg
VITAMIN C
        330,0 mg
PHARMACOLOGICAL CLASSIFICATION:
A 5.8 : Preparations for the common cold including nasal decongestants and antihistaminics.
PHARMACOLOGICAL ACTION:
FLUTEX EFFERVESCENT tablets have analgesic, antipyretic, antihistaminic and decongestant properties.
INDICATIONS:
Symptomatic relief of minor aches and pains, and sinus and nasal congestion associated with colds and flu.
CONTRA-INDICATIONS:
Hypersensitivity to any of the ingredients.
Coronary disease and cardiovascular disease such as ischaemic heart disease, arrhythmia or tachycardia.
Safety in pregnancy and lactation has not been established.
Patients sensitive to one antihistamine may be sensitive to others.
Patients receiving monoamine oxidase inhibitor treatment, or within 14 days of stopping such treatment.
Severe liver function impairment. Flutex Effervescent tablets should not be administered to children under the age of
12 years.
WARNINGS:
Consult a doctor if no relief is obtained from the recommended dosage.
Do not use this product for more than 7 days without consulting a doctor.
Store in a safe place out of reach of children.
May lead to